6531 POSTER XPD 312 single nucleotide polymorphism (SNP) predicts survival in stage IIIA–B non-small-cell lung cancer (NSCLC) patients (pts) < 59 years (y) treated with chemotherapy followed by surgery.

Details

Language :

English

ISSN :

13596349

Volume :

5

Issue :

4

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

27457459

Full Text :

https://doi.org/10.1016/S1359-6349(07)71359-9